In vivo bioluminescence imaging of the spatial and temporal colonization of lactobacillus plantarum 423 and enterococcus mundtii ST4SA in the intestinal tract of mice by Van Zyl, Winschau F. et al.
RESEARCH ARTICLE Open Access
In vivo bioluminescence imaging of the
spatial and temporal colonization of
lactobacillus plantarum 423 and
enterococcus mundtii ST4SA in the
intestinal tract of mice
Winschau F. Van Zyl1, Shelly M. Deane2 and Leon M. T. Dicks2*
Abstract
Background: Lactic acid bacteria (LAB) are major inhabitants and part of the normal microflora of the gastrointestinal
tract (GIT) of humans and animals. Despite substantial evidence supporting the beneficial properties of LAB, only a few
studies have addressed the migration and colonization of probiotic bacteria in the GIT. The reason for this is mostly
due to the limitations, or lack of, efficient reporter systems. Here we describe the development and application of a
non-invasive in vivo bioluminescence reporter system to study, in real-time, the spatial and temporal persistence of
Lactobacillus plantarum 423 and Enterococcus mundtii ST4SA in the intestinal tract of mice.
Results: This study reports on the application of the firefly luciferase gene (ffluc) from Photinus pyralis to develop
luciferase-expressing L. plantarum 423 and E. mundtii ST4SA, using a Lactococcus lactis NICE system on a high copy
number plasmid (pNZ8048) and strong constitutive lactate dehydrogenase gene promoters (Pldh and STldh). The
reporter system was used for in vivo and ex vivo monitoring of both probiotic LAB strains in the GIT of mice after
single and multiple oral administrations. Enterococcus mundtii ST4SA reached the large intestine 45 min after gavage,
while L. plantarum 423 reached the cecum/colon after 90 min. Both strains predominantly colonized the cecum and
colon after five consecutive daily administrations. Enterococcus mundtii ST4SA persisted in faeces at higher numbers
and for more days compared to L. plantarum 423.
Conclusions: Our findings demonstrate the efficiency of a high-copy number vector, constitutive promoters
and bioluminescence imaging to study the colonization and persistence of L. plantarum 423 and E. mundtii
ST4SA in the murine GIT. The system allowed us to differentiate between intestinal transit times of the two
strains in the digestive tract. This is the first report of bioluminescence imaging of a luciferase-expressing E.
mundtii strain to study colonization dynamics in the murine model. The bioluminescence system developed
in this study may be used to study the in vivo colonization dynamics of other probiotic LAB.
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Background
Lactic acid bacteria are common inhabitants of a healthy
human and animal gastrointestinal tract and they play a
major role in keeping the gut microbiota in a balanced
state [1–4]. Beneficial properties include the inhibition of
enteric pathogens [5], alleviation of constipation [6] and
diarrhoea [7], stimulation of the immune system [8],
repression of cancer cell and tumor growth [9, 10], and
synthesis of essential metabolites such as vitamins [11].
For probiotics to confer their beneficial effects on the host,
they must be able to survive stomach acids and bile salts
and persist at high levels in the intestinal tract [12]. Some
strains have adapted to these harsh conditions by
over-expressing specific genes when exposed to acids and
bile salts [13–15].
The survival and colonization of LAB in the GIT is
usually studied in vitro and ex vivo by using models simu-
lating the GIT [16–19]. Although these studies are valu-
able in understanding the survival of LAB in the GIT, the
findings seldom reflect real-life conditions. More in vivo
studies are needed to understand the interactions between
probiotic bacteria, pathogens, commensal bacteria and gut
epithelial cells. The best approach to study real-time inter-
actions between probiotic bacteria and their mammalian
host in the GIT is by labelling the cells with fluorescent or
bioluminescent markers [20–26]. A selection of genes, en-
coding proteins that emit light at specific wavelengths, are
available for cloning into plasmids or insertion into the ge-
nomes of recipient cells [21, 22]. The most commonly
used luciferase labelling systems used in in vivo and ex
vivo tracking of bacteria are bacterial luxABCDE from
Photorabdus luminescence [26], click beetle luciferase
(CBluc) from Pyrophorus plagiophthalamus [23] and fire-
fly luciferase (Ffluc) from Photinus pyralis [25]. The CBluc
and Ffluc luciferases require the exogenous addition of
D-Luciferin, whereas the lux substrate is synthesized by
proteins encoded in the lux operon [20]. The half-life of
luciferase is only several seconds and does not represent
bioluminescence accumulated over a period [28]. Another
advantage is that only low levels of background lumines-
cence are emitted by mammalian tissue.
To date, very few studies have used either fluorescence
or bioluminescence whole-body imaging to monitor the
persistence of LAB in the GIT, and with variable degrees
of success. This is mostly due to the weak penetration of
photons through muscles and tissue. Furthermore, la-
belled cells orally administered are often dispersed
throughout the GIT or become metabolically inactive and
emit bioluminescent signals too weak to detect. Cronin et
al. [29] used a bacterial lux system to study the persistence
of Bifidobacterium breve in mice. The bioluminescent sig-
nal was, however, not emitted from the GIT of live mice
and all imaging had to be done ex vivo after dissecting the
GIT. In our own studies [24], fluorescence encoded by the
mCherry gene, transformed into Lactobacillus plantarum
423 and Enterococcus mundtii ST4SA, was also only de-
tected after surgical removal of the GIT. This is not un-
usual, as also reported by Oozeer et al. [26] and Corthier
et al. [30] with studies done on mice. Lee and Moon [31]
were one of the first to detect Lc. lactis in the GIT of live
mice by using a pMG36e Ffluc plasmid vector, although
the strain could only be detected for up to 2 h. Berlec and
coworkers [25] successfully used the infrared fluorescent
protein IRFP713 to monitor Lactococcus lactis, L. plan-
tarum and Escherichia coli in the GIT of mice. The viru-
lence gene expression and gut persistence abilities of two
pathogenic Enterococcus faecalis strains were studied
using the bacterial luxABCDE cassete [32].In another
study, Daniel et al. [33] successfully monitored the
colonization and persistence of Lc. lactis and L. plantarum
in live mice using the CBluc luciferase system.
Lactobacillus plantarum 423, isolated from sorghum
beer and E. mundtii ST4SA, isolated from soybeans
both have probiotic properties [34–36]. The strains sur-
vive conditions in the human GIT, as shown with stud-
ies using a model simulating the intestinal conditions
of infants [16]. Both strains adhere to human intestinal
epithelial cells [37] and produce antimicrobial peptides
[38, 39], active against Listeria monocytogenes, Entero-
coccus faecalis, Clostridium sporogenes and Salmonella
typhimurium [34, 35, 40–42]. In a previous report,
using the mCherry fluorescence gene, we have shown
that L. plantarum 423 and E. mundtii ST4SA were lo-
calized in the cecum and colon of mice after a single
oral dosage [24].
This study reports on the application of a red-shifted
thermostable firefly luciferase-system (Ffluc) to study the
spatial and temporal persistence of L. plantarum 423 and
E. mundtii ST4SA in the GIT of mice after single and
multiple dosages. The use of a red-emitting luciferase with
a longer wavelength (620 nm) enabled optimal light pene-
tration through intestinal and skin tissue. The in vitro and
in vivo expression of the Ffluc system was optimized using
a combination of a high-copy number plasmid vector and
strong constitutive promoters. Differences between the
two strains in viability and persistence in the GIT of mice
were demonstrated by monitoring in vivo and ex vivo bio-
luminescence, using the Caliper in vivo imaging system
(IVIS; Caliper Life Sciences, Hopkinton, MA). The bio-
luminescence system also allowed tracking of each of the
strains in different sections of the GIT.
Results
In vitro functionality and stability of bioluminescent L.
plantarum 423 and E. mundtii ST4SA
Bacterial cultures resuspended in phosphate buffered
saline (PBS) were used to image the intensity of bio-
luminescent signals produced by L. plantarum 423
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Fluc and E. mundtii ST4SA Fluc (Fig. 1a). No signifi-
cant difference was observed in the maximum intensities
of bioluminescent signals produced by L. plantarum 423
Fluc or E. mundtii ST4SA Fluc. Maximum bioluminescence
was recorded for E. mundtii ST4SA Fluc with a mean value
of 2.49 × 108 photons per second (p/s), while a slightly
lower mean value of 1.94 × 108 p/s was recorded for L.
plantarum 423 Fluc. None of the control strains (L. plan-
tarum 423 (pNZ8048) or E. mundtii ST4SA (pNZ8048)),
emitted bioluminescent signals. No bioluminescence was
detected in culture supernatants of L. plantarum 423 Fluc
or E. mundtii ST4SA Fluc, indicating that bioluminescent
light production was strictly intracellular.
Bioluminescence emitted by cells that expressed firefly lu-
ciferase correlated with serial dilutions of total CFUs of cul-
tures of L. plantarum 423 Fluc (R2 = 0.9830) and E.
mundtii ST4SA Fluc (R2 = 0.9870), indicating that photon
emission accurately reflects bacterial cell numbers (Fig. 1b
and c). The bioluminescence signal corresponded to the de-
tection of bacterial CFU over a broad range, from approxi-
mately 6 × 106 CFU to 8.5 × 108 CFU for L. plantarum 423
Fluc (Fig. 1b) and from approximately 1 × 107 CFU to 2 ×
109 CFU for E. mundtii ST4SA Fluc (Fig. 1c).
No significant difference in growth was observed be-
tween wild-types (WT) L. plantarum 423 and E. mundtii
ST4SA and recombinants L. plantarum 423 Fluc and E.
mundtii ST4SA Fluc, respectively, after 9 h of growth (not
shown). Bioluminescent light production and the presence
of the luciferase expressing plasmids in recombinant L.
plantarum 423 Fluc and E. mundtii ST4SA Fluc strains
had no detectable effect on bacterial growth. The stability
of the luciferase-expressing plasmids pNZPldhFfluc in L.
plantarum 423 Fluc and pNZSTldhFfluc in E. mundtii
ST4SA Fluc was tested in vitro by subculturing for up to
7 days with replica-plating on non-selective and selective
media (Additional file 1: Figure S1a). The stability of the
autonomous plasmids in L. plantarum 423 Fluc and E.
mundtii ST4SA Fluc transformants was indicated by 100%
plasmid retention and retained resistance to Cm following
culturing for 7 days in the absence of the antibiotic. The
bioluminescent signals of the recombinant strains were
also imaged with the IVIS in parallel to replica plating
(Additional file 1: Figure S1b and c).
Colonization dynamics of bioluminescent L. plantarum
423 and E. mundtii ST4SA in the GIT of mice after a single
dosage
To determine the spatial and temporal colonization of L.
plantarum 423 Fluc and E. mundtii ST4SA Fluc after a
single oral administration, groups of mice (n = 13, per
strain) were monitored over a 24 h period by transcutane-
ous in vivo bioluminescence imaging (BLI) and ex vivo
BLI of GITs and faeces. The viable bacteria numbers in
the GIT and faecal samples were also recorded. Three
anesthetised mice (n = 3, per strain) were imaged at 15
and 30 min and, 1, 1.5, 2, 3, 4, 6 and 24 h after the admin-
istration of L. plantarum 423 Fluc and E. mundtii ST4SA
Fluc, respectively (Fig. 2). The same three mice were used
throughout the 24 h trial period. At time zero (before
administration) no bioluminescence was recorded (back-
ground signal corresponded to approximately 3 × 104 p/s).
A maximum bioluminescent signal of approximately 2 ×
108 p/s was detected for L. plantarum 423 Fluc and E.
mundtii ST4SA Fluc at 1 h and 30 min, respectively. The
bioluminescent signal of L. plantarum 423 Fluc remained
at high levels until 2 h, but declined to lower levels 1 h
later (mean value of approximately 9 × 106 p/s). The
bioluminescent signal of L. plantarum 423 Fluc remained
at a plateau (mean value of approximately 4 × 105 p/s)
until 6 h. The bioluminescent signal of E. mundtii ST4SA
Fluc steadily declined between 1 and 6 h and was signifi-
cantly higher than that observed for L. plantarum 423
Fluc between 3 and 4 h. After 24 h, no bioluminescent
signal could be detected for L. plantarum 423 Fluc (back-
ground level), whereas the signal of E. mundtii ST4SA
Fluc declined to approximately 2 × 105 p/s.
Next, the localization of bioluminescent L. plantarum
423 Fluc and E. mundtii ST4SA Fluc in the GITs of mice
after oral administration was determined by ex vivo im-
aging and recording viable cell numbers in the small and
large intestinal tracts (Fig. 3). Results showed that
15 min after administration of bacterial strains, both L.
plantarum 423 Fluc and E. mundtii ST4SA Fluc sur-
vived passage through the stomach by the observation of
high cell numbers and bioluminescent cells throughout
the small intestine (Fig. 3a and b). After approximately
45 min, bioluminescent cells of E. mundtii ST4SA Fluc
reached the cecum and colon. From 90 to 240 min after
oral administration of bacteria to mice, the majority of
bioluminescent L. plantarum 423 Fluc and E. mundtii
ST4SA Fluc had travelled through the small intestine
and were located exclusively in the cecum and colon.
Some of the viable cells of both strains remained in the
small intestine after 90 min, but emitted weak or no bio-
luminescence signals (Fig. 3b). No bioluminescence of
either strain was detected in the large intestine 15 min
(Fig. 3a) after intragastric administration, suggesting that
the viable cells’ bioluminescence emission was below the
detection limit of the IVIS through the intestinal tissue
or the cells were metabolically inactive (Fig. 3c). After
24 h, a significantly higher number of viable E. mundtii
ST4SA Fluc was detected in the cecum/colon compared
to L. plantarum 423 Fluc.
Colonization of L. plantarum 423 Fluc and E. mundtii
ST4SA Fluc in the GIT of mice was also determined by
monitoring the number of viable bacterial cells in faeces
at different time points after intragastric administration
(Fig. 4a). The respective bioluminescent signals of L.
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Fig. 1 Quantification of bioluminescent L. plantarum 423 Fluc and E. mundtii ST4SA Fluc. a Bioluminescence measured in cultures of L. plantarum
423 Fluc and E. mundtii ST4SA Fluc distributed in black 96-well microtitre plates. Means from six independent cultures (4 × 109 CFU per culture)
are shown with standard deviations, and the background from each strain has been subtracted from each respective measurement. Correlation
between bioluminescent signals and bacterial cell numbers of (b) L. plantarum 423 Fluc and (c) E. mundtii ST4SA Fluc. Cultures of each strain
were serially diluted in black microplates and the bioluminescent signals quantified using the IVIS and then correlated with CFUs. Log10 averages
of three cultures are plotted, with error bars indicating standard deviations. The logarithmic trendline and the correlation of determination (R2)
between bioluminescence measurements and bacterial numbers of each strain are shown
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plantarum 423 Fluc and E. mundtii ST4SA Fluc in faeces
were also monitored with the IVIS (Fig. 4b). High cell
numbers of both strains were excreted in the faeces and
were proportionate to the respective bioluminescence sig-
nals emitted. The bacterial populations of both strains in
faeces increased with time. Both strains reached a max-
imum number of approximately 2 × 108 CFU/100 mg fae-
ces after 4 h and remained at this level for the following
2 h. These peaks correlated excellently with maximum
bioluminescent signals of approximately 4 × 106 p/s/
100 mg of faeces for L. plantarum 423 Fluc and 2 × 107 p/
s/100 mg of faeces for E. mundtii ST4SA Fluc, from 4 to
6 h. The maximum level of viable E. mundtii ST4SA Fluc
cells shed in the faeces was significantly higher in the first
2 h, reaching approximately 8 × 107 p/s/100 mg of faeces.
Bioluminescence signals emitted by E. mundtii ST4SA
Fluc cells in the faeces were higher compared to those of
L. plantarum 423 Fluc throughout the 24 h study period.
After 24 h, the number of L. plantarum 423 Fluc declined
to approximately 4 × 104 CFU/100 mg faeces with no bio-
luminescent signal (background), while E. mundtii ST4SA
Fluc cells declined to approximately 1 × 105 CFU/100 mg
faeces with a weak bioluminescent signal of 1.5 × 104 p/s/
100 mg of faeces.
Persistence of bioluminescent L. plantarum 423 and E.
mundtii ST4SA in the GIT of mice after five oral dosages
In vivo bioluminescent signals were measured everyday
(1 h after administration of bacteria to mice on days 1
to 5) for nine days after two groups of mice (n = 22, per
strain) each received daily doses of L. plantarum 423
Fluc and E. mundtii ST4SA Fluc for five consecutive
days (Fig. 5). The experimental design is described in
Fig. 5a. High intensity bioluminescence was emitted by
mice in both groups from days 1 to 5. Highest bio-
luminescent signals were recorded for E. mundtii
ST4SA Fluc (mean = 4.27 × 108 p/s) compared to L.
plantarum 423 Fluc (mean = 7.78 × 107 p/s) during the
a
b
Fig. 2 Monitoring of L. plantarum 423 and E. mundtii ST4SA colonization in the digestive tract of mice by bioluminescence imaging in whole
animals after one oral administration. Lactobacillus plantarum 423 Fluc and E. mundtii ST4SA Fluc were fed intragastrically (4 × 109 CFU) to two
sets of three mice (n = 3, per strain). The bioluminescent signals in log10 photons/s measured from whole animals at different time-points over a
24 h period (a) are plotted, with standard deviations. Significant statistical differences between the bioluminescence signals of the two groups of
mice are indicated with three asterisks (P < 0.001); Mann-Whitney nonparametric test). The background bioluminescence signal (approximately
4 × 104 p/s) emitted is represented by a dashed line. b Visual images of bioluminescence emission in whole animals by mice fed once with L.
plantarum 423 Fluc or E. mundtii ST4SA Fluc. In each case, one representative image of one mouse is shown. The intensity of the photon emission
is represented as a pseudo-color image. One representative scale bar is shown (p/s)
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first 5 days. After 6 days the signal for L. plantarum
423 Fluc rapidly declined to approximately 1 × 105 p/s,
while the signal for E. mundtii ST4SA Fluc declined to
approximately 5 × 105 p/s. From day 6, the L. plan-
tarum 423 Fluc bioluminescent signal remained at a
plateau until day 9 (approximately 1 × 105 p/s). The E.
mundtii ST4SA Fluc bioluminescent signal declined to
approximately 2 × 105 p/s on day 7 and to approxi-
mately 8 × 104 p/s after 9 days.
The intestines of mice were imaged ex vivo to de-
termine which sections of the GIT the bacterial
strains colonized after 5 oral administrations (Fig. 6).
On day 1, both strains were detected throughout the
small intestine 30 min after oral administration of
bacteria. From day 2 to day 5, both strains were de-
tected in the jejunum and ileum sections of the small
intestine (jejunum and ileum) and in both the cecum
and colon sections of the large intestinal tract. At
days 6 and 7 (1 and 2 days after last bacterial dose),
L. plantarum 423 Fluc colonized the small intestine
and cecum readily, but the bioluminescent signal de-
tected from the small intestine progressively declined
and by day 9 a very weak or no bioluminescent signal
remained (Fig. 6a). On day 9, L. plantarum 423 Fluc
was predominantly localized in the cecum and colon.
From day 6 to day 9, E. mundtii ST4SA Fluc colo-
nized the upper section of the small intestine and the
cecum/colon most prominently (Fig. 6b).
a
b
c
Fig. 3 Transit of L. plantarum 423 and E. mundtii ST4SA through the digestive tract of mice after one oral administration. Groups of mice were
gavaged once with 4 × 109 CFU of L. plantarum 423 Fluc or E. mundtii ST4SA Fluc and the intestines resected at 15, 45, 90, 180, 240 min and 24 h.
At each time point two mice (n = 12, per strain) were sacrificed, and (a) one representative image of one mouse and its GIT are shown. Persistence of
viable L. plantarum 423 Fluc or E. mundtii ST4SA Fluc cells in (b) the small and (c) large intestinal tract of mice sacrificed at time points indicated in A.
The limit of detection was approximately 4 × 104 p/s. Significant differences between the two groups were assessed using the Mann-Whitney
nonparametric test are indicated with asterisks (P < 0.001)
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Viable counts of the small and large intestine taken
on days 1 to 5 revealed high numbers (approximately
108 CFU) of both L. plantarum 423 Fluc and E. mund-
tii ST4SA Fluc (Fig. 6c and d). At day 7 (2 days after
last bacterial dose), the colonization of the large intes-
tine (mean value of 3 × 105 CFU) by L. plantarum 423
Fluc was 10-fold superior to that of the small intestine
(mean value of 3 × 106 CFU). Two days later, the differ-
ence between the amount of viable L. plantarum 423
Fluc cells in the small (mean value of 9 × 102 CFU) and
large intestine (mean value of 8 × 104 CFU) increased to
100-fold. In the case of E. mundtii ST4SA Fluc, the
number of viable cells in the small intestine increased
from approximately 1 × 103 CFU on day 6 to 2 ×
104 CFU on day 9. On day 9, mice administered with L.
plantarum 423 Fluc harboured approximately 9 ×
104 CFU in the cecum/colon, while mice administered
E. mundtii ST4SA Fluc harboured approximately 7 ×
104 CFU in the cecum/colon. After 20 days, no L.
plantarum 423 Fluc were detected in the intestines of
mice. However, the number of E. mundtii ST4SA Fluc
cells in the small intestine was still approximately 1.4 ×
103 CFU and 5 × 103 CFU in the large intestine.
Persistence of L. plantarum 423 and E. mundtii ST4SA in
faeces after five oral dosages
The persistence of bioluminescent L. plantarum 423
Fluc and E. mundtii ST4SA Fluc in faeces and their re-
spective bioluminescent signals were monitored every
day for 20 consecutive days (Fig. 7a and b). Enterococcus
mundtii ST4SA Fluc persisted in the faeces throughout
the trial, with significantly higher cell numbers recorded
at days 4, 19 and 20 compared to L. plantarum 423 Fluc.
The maximum number of viable E. mundtii ST4SA Fluc
cells in faeces was excreted at day 4 (approximately 2 ×
108 CFU/100 mg faeces). From day 4 to 9 the level of E.
mundtii ST4SA Fluc cells in faeces declined to approxi-
mately 1 × 104 CFU/100 mg faeces. After day 9 there is a
0 1 2 3 4 5 6
100
102
104
106
108
101 0
20 22 24
423
ST4SA
***
*
Hours
L
og
1
0 
C
F
U
/1
00
m
g 
fa
ec
es
0 1 2 3 4 5 6
10 2
10 4
10 6
10 8
101 0
20 22 24
ST4SA
423
***
*
Hours
ph
ot
on
s/
s/
10
0m
g 
of
 fa
ec
es
a
b
Fig. 4 Presence of L. plantarum 423 and E. mundtii ST4SA in the faeces of mice after a single oral administration. Groups of three mice
each (n = 3, per strain) were administered once with 4 × 109 CFU L. plantarum 423 Fluc or E. mundtii ST4SA Fluc. At each time point,
log10 averages of the (a) cell counts per 100 mg faeces and the corresponding (b) bioluminescence in log10 p/s per 100 mg faeces for
each group of three mice are plotted with standard deviations. Significant differences between the two groups were assessed using the
Mann-Whitney nonparametric test and are indicated with one (P < 0.05) or three (P < 0.001) asterisks. The background bioluminescence
signal (approximately 5 × 103 p/s) emitted is represented by a dashed line
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slight increase in the number of E. mundtii ST4SA Fluc
cells in faeces until day 11 after which levels of approxi-
mately 104 to 105 CFU/100 mg faeces were maintained
from days 12 to 20. Lactobacillus plantarum 423 Fluc,
on the other hand, reached a maximum level of approxi-
mately 2 × 108 CFU/100 mg faeces at day 1 and then
steadily declined until day 19 (mean value of 1 ×
104 CFU/100 mg faeces). Lactobacillus plantarum 423
Fluc persisted for only 13 days in faeces after the last
day of intragastric administration of bacteria (day 5).
The bioluminescent signal of E. mundtii ST4SA Fluc
cells in faeces was detected throughout the trial period,
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Fig. 5 Monitoring of colonization and persistence of L. plantarum 423 and E. mundtii ST4SA in the GIT of mice by bioluminescence imaging in
whole animals after five daily administrations. a The experimental design. Lactobacillus plantarum 423 Fluc and E. mundtii ST4SA Fluc were fed
once daily by intragastric gavage (4 × 109 CFU) to two groups of mice (n = 22, per strain) for five consecutive days (days 1 to 5). The bioluminescent
signals in log10 photons/s measured in whole animals from day 1 to 9 for each set of three mice (b) are plotted, with standard deviations. No
statistical differences between the bioluminescence signals of the two groups of mice were observed. The background bioluminescence
signal (approximately 4 × 104 p/s) emitted is represented by a dashed line. c Visual images of bioluminescence emission in whole animals by
mice fed once daily for five consecutive days with L. plantarum 423 Fluc or E. mundtii ST4SA Fluc. One representative image of one mouse is
shown. The intensity of the photon emission is represented as a pseudo-color image. One representative scale bar is shown (p/s)
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while the L. plantarum 423 Fluc bioluminescent signal
declined to the background level at day 19. The peaks
of the amount of viable cells per 100 mg faeces of both
strains correlated perfectly with the amount of bio-
luminescent signals emitted at different time points.
The bioluminescent signal of L. plantarum 423 Fluc
was detected at lower levels between days 2 and 6, but
displayed levels similar to those observed for E. mundtii
ST4SA Fluc from day 7 until 18. The bioluminescent
system allowed the detection of both L. plantarum 423
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Fig. 6 Comparison of colonization abilities of L. plantarum 423 and E. mundtii ST4SA in the GIT of mice after five daily oral administrations.
Lactobacillus plantarum 423 Fluc and E. mundtii ST4SA Fluc were fed once daily by oral gavage (4 × 109 CFU) to two groups of mice (n = 18, per
strain) for five consecutive days (days 1 to 5). Four mice (two per group) were sacrificed from day 1 to 9, and a representative image of the GIT of
one mouse is shown (days 1 to 9) in mice fed with (a) L. plantarum 423 Fluc or (b) E. mundtii ST4SA Fluc. Persistence of viable L. plantarum 423
Fluc or E. mundtii ST4SA Fluc cells in (c) the small and (d) large intestinal tract of mice sacrificed at time points indicated in A and B and day 20.
The limit of detection was approximately 4 × 104 p/s
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Fluc and E. mundtii ST4SA Fluc viable cells in faeces
as low as 104 CFU/100 mg faeces.
Discussion
A major advantage of using the BLI technique com-
pared to conventional approaches is that it allows for
drastic reductions in the number of animals to be
sacrificed to establish the precise location of bacteria
in mouse or rat models [20]. Moreover, more informa-
tion is gathered over a shorter period per experiment
compared to traditional pre-clinical animal trials [21].
Mouse models provide a complex whole body system
for the non-invasive real-time monitoring of bio-
luminescent probiotic LAB through the GIT of the
mammalian host [43]. The murine model is the pre-
dominant choice for the in vivo evaluation of probiotic
properties and has been used to study the persistence
and localization of potential probiotic LAB in several
studies [21, 24, 27, 33, 43]. In the current study, an
IVIS system and the BLI technique were used to study the
colonization dynamics of the probiotic LAB strains L.
plantarum 423 and E. mundtii ST4SA in the GIT of mice.
The stable expression of reporter genes during in vivo
imaging is an absolute prerequisite for the detection of
luminescent light through animal tissues. Stable expres-
sion of reporter genes depends on the nature of the ex-
pression vector used, including the promoters used to
drive expression and plasmid copy numbers. With this
in mind, expression of the firefly luciferase gene from
P. pyralis (ffluc) was optimized for use in L. plantarum
423 and E. mundtii ST4SA. Results in this study dem-
onstrate that highest bioluminescence signals were
achieved using the pNZ8048 high-copy number plas-
mid [44] for luciferase gene expression (Fig. 1).
Attempts to use a low-copy number plasmid and chro-
mosomally integrated ffluc genes in L. plantarum 423
and E. mundtii ST4SA resulted only in the emission of
weak and inconsistent bioluminescent signals (not
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Fig. 7 Persistence of L. plantarum 423 and E. mundtii ST4SA in mouse faeces after five daily oral administrations. Groups of three mice (n = 3, per
strain) each were administered once daily (days 1 to 5) with 4 × 109 CFU L. plantarum 423 Fluc or E. mundtii ST4SA Fluc for five consecutive days.
Mouse faeces were collected daily from days 1 to 20. At each time point, log10 averages of the a cell counts per 100 mg faeces and the corresponding
b bioluminescence in log10 p/s per 100 mg faeces for each group of three mice are plotted with standard deviations. Significant differences between
the two groups were assessed using the Mann-Whitney nonparametric test and are indicated with one (P < 0.05), two (P < 0.01) or three (P < 0.001)
asterisks. The background bioluminescence signal (approximately 5 × 103 p/s) emitted is represented by a dashed line
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shown). The former results are most likely linked to the
presence of multiple copies of the pNZ8048 plasmid
that in turn leads to higher expression levels of the ffluc
gene within the respective LAB hosts. The expression
of reporter genes in bacteria using plasmids is widely
used. Bacterial plasmids play an important role in the
ability of bacteria to adapt in diverse environments
[45]. However, when introducing a new recombinant
plasmid harbouring a reporter gene, it is critical to
evaluate its stability and persistence within the bacterial
host with and without antibiotic pressure. This study
demonstrates that in vitro ffluc expression plasmids
were remarkably stable in L. plantarum 423 Fluc and E.
mundtii ST4SA Fluc and that bioluminescence did not
affect the growth of the respective host strains com-
pared to the WT derivatives (see Additional file 1). We
have previously demonstrated plasmid stability in E.
mundtii ST4SA [24]. In terms of promoter selection,
the lactate dehydrogenase gene (ldh) promoters of L.
plantarum 423 and E. mundtii ST4SA, respectively,
drove highest ffluc gene expression. The L. plantarum
ldh gene promoter has been used for the constitutive
expression of genes in LAB in several studies [24, 33,
46, 47]. These results demonstrated that both L. plan-
tarum 423 Fluc and E. mundtii ST4SA Fluc could pro-
duce bioluminescence with no loss of the firefly
luciferase-expressing plasmids.
The current study was designed to study the colonization
(spatial and temporal) dynamics of L. plantarum 423 and
E. mundtii ST4SA orally inoculated once or for five con-
secutive days over a period of 24 h and 20 days, respect-
ively. Strong bioluminescence signals emitted by L.
plantarum 423 Fluc and E. mundtii ST4SA Fluc could be
detected as soon as 15 min after oral administration with a
single bacterial dosage of the respective strains (Fig. 2). The
bioluminescence signals of both strains as recorded with
whole body imaging showed an overall decline after a single
oral administration to mice. This is an indication that the
probiotic strains only transiently colonized the GIT of mice
after a single oral administration. In a previous report, using
the mCherry fluorescence gene and a conventional
culture-based method, we showed similar transit dynamics
of viable L. plantarum 423 and E. mundtii ST4SA after a
single dose of each bacterial strain [24]. However, we could
not obtain fluorescence signals from in vivo whole body im-
aging for real-time analysis and could only locate the bac-
terial strains in the GIT after killing the animals.
Interestingly, in the current study bioluminescence signals
were detected up to 6 h in whole animals fed with either L.
plantarum 423 or E. mundtii ST4SA and up to 24 h in
mice fed with E. mundtii ST4SA. Eom et al. [27] could not
detect a bioluminescence signal after 3 h from mice admin-
istered bioluminescent L. casei CJNU 0588. Based on whole
body bioluminescence imaging in real-time, these results
clearly reflect the superior active replication and
colonization abilities of L. plantarum 423 and E. mundtii
ST4SA in the mouse GIT compared to L. casei CJNU 0588.
The bacterial transit time in the GIT for viable L.
plantarum 423 and E. mundtii ST4SA varied. Lactoba-
cillus plantarum 423 showed a slower transit and was
detected in the lower part of the jejunum and in the
ileum 45 min post gavage, while E. mundtii ST4SA was
detected in the ileum, cecum and colon (Fig. 3a). Simi-
larly, Karimi et al. [48] demonstrated that the gastro-
intestinal transit time differs between strains of L.
reuteri, using fluorescence and bioluminescence im-
aging techniques. However, the authors did not select-
ively monitor the bacterial cell numbers of the LAB
strains present in gastrointestinal tissue or stool sam-
ples. Although it was shown in the current study that
there is excellent correlation between bioluminescence
and bacterial load, it is important to verify that a cer-
tain level of bioluminescence correlates to a certain
number of cells. Enumeration of viable counts in dis-
sected intestines revealed that both bioluminescent
LAB strains were located predominantly in the large in-
testine (cecum/colon) 3 h post gavage (Fig. 3b). No bio-
luminescent cells of L. plantarum 423 or E. mundtii
ST4SA were detected in the stomach or duodenum
compartments 45 min after intragastric administration
of the respective bacteria (Fig.3a). These results are in-
dicative of the harsh conditions the LAB strains are ex-
posed to in those compartments of the GIT and may be
the reason for the rapid transit in those sections of the
gut. The CFU counts revealed the presence of viable
cells of L. plantarum 423 and E. mundtii ST4SA in the
small intestine at 4 and 24 h post gavage, but no bio-
luminescent signals could be detected. This might be
caused by reduced cell activity or the inhibition of pro-
tein synthesis during passage in the stomach and duo-
denum compartments of the gut, which leads to
inefficient bioluminescence emission. Bioluminescent
light can only be produced in metabolically active cells
[20]. Both strains could be detected in the cecum and
colon after 4 h, indicating the metabolically active state
of the bacteria in the large intestine (Fig. 3a).
After 24 h, no bioluminescent signal could be de-
tected from mice administered with L. plantarum 423,
while a detectable bioluminescent signal was still ob-
served from mice fed with E. mundtii ST4SA (Fig. 2).
This indicates that L. plantarum 423 was eliminated
from the GIT of mice more rapidly than E. mundtii
ST4SA, and is associated with a significantly higher
amount of viable E. mundtii ST4SA in the large intes-
tine compared to L. plantarum 423 (Fig. 3c). These
findings are in agreement with previous studies [33,
48] reporting on the gastrointestinal transit of Lacto-
bacillus reuteri, L. plantarum and Lactococcus lactis.
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The authors showed that the intestinal transit times
differed between two strains of L. reuteri, and that a
Lc. lactis strain had shorter survival times in the GIT
compared to a L. plantarum strain. Lactobacillus
plantarum 423 and E. mundtii ST4SA were excreted
in high numbers in the faeces of mice over the 24 h
period, but it is clear that a small amount of each LAB
strain persisted in the GIT after a single oral dose as
demonstrated with intestinal tissue CFU counts (Figs.
3 and 4). Bioluminescence signals from bacteria in fae-
cal material accurately reflected CFU data and this
serves as an indication that the plasmids are retained
in vivo to a large extent.
To study more thoroughly the persistence of the bio-
luminescent strains in the GIT, mice were administered
orally with either L. plantarum 423 or E. mundtii ST4SA
for five consecutive days. Our results demonstrate that L.
plantarum 423 and E. mundtii ST4SA had similar GIT
transit dynamics during the first 5 days of administration
of the respective strains to mice, despite the detection of
higher bioluminescent signals for E. mundtii ST4SA com-
pared to L. plantarum 423 (Fig. 5). At day 6 (one day after
last bacterial dosage), the in vivo bioluminescent signals of
both strains declined to low levels but were maintained at
similar levels for the next 3 days. This suggests that while
most of the administered bacteria transited the GIT of
mice, small populations of both strains persisted until day
9 (4 days after last bacterial dosage). Overall, the gastro-
intestinal persistence of L. plantarum 423 and E. mundtii
ST4SA compared well to several other commercial pro-
biotic strains, including Lactobacillus rhamnosus GG, Bifi-
dobacterium lactis LAFTI B94, L. plantarum 299v and
Lactobacillus gasseri SBT2055 [49–52]. These observa-
tions were confirmed by ex vivo imaging of dissected in-
testines (Fig. 6a and b). At day 9, bioluminescent cells of
both strains were predominantly localized in the cecum
and colon. It has been suggested that the murine cecum
may be the site where microorganisms adapt to the
gastrointestinal environment and where the activation of
genes required for colonization of the colon occur [29].
Interestingly, the cecum and colon have also been shown
to be the major sites of colonization of several enteric
pathogens including E. coli O157:H7, Citrobacter roden-
tium, Yersinia enterocolitica, L. monocytogenes and S.
typhimurium [42, 53–56]. Both L. plantarum 423 and E.
mundtii ST4SA have been demonstrated to exclude path-
ogens such as L. monocytogenes, S. typhimurium, C. sporo-
genes and E. faecalis in in vitro or in vivo competitive
exclusion experiments [40–42]. The presence of persistent
populations of L. plantarum 423 and E. mundtii ST4SA in
the murine cecum/colon as demonstrated in this study
suggest that their presence may have prevented the patho-
genic bacteria from becoming established. It is also inter-
esting to note that the population of E. mundtii ST4SA in
the small intestine increased until day 9 compared to that
of L. plantarum 423 (Fig. 6c). This could explain why mice
pre-colonized with E. mundtii ST4SA showed a more
rapid decline in L. monocytogenes EGDe cell numbers
compared L. plantarum 423 in a competitive exclusion
experiment [42]. Enterococcus mundtii ST4SA cells were
able to persist in the faeces of mice throughout the trial
period (Fig. 7). In contrast, L. plantarum 423 could not be
detected in faeces after 13 days after the last oral adminis-
tration to mice and in lower numbers compared to E.
mundtii ST4SA. Based on bioluminescence, the amount
of bacteria administered to mice per day (4 × 109 CFU)
and the amount of E. mundtii ST4SA cells shed in the fae-
ces per day, there is a clear indication that E. mundtii
ST4SA persists better than L. plantarum 423 in the mur-
ine GIT of mice. Since the same dosage and administra-
tion methods were used for both strains, the difference in
the intestinal persistence between the two probiotic
strains might be due to differences in the physiological
and genotypic properties of the strains.
Conclusions
The construction and optimization of LAB reporter
strains is an important step towards a better understand-
ing of the route and destination of orally administered
probiotics in the GIT, and the interactions between pro-
biotics and the host. This study demonstrates the applica-
tion of the firefly luciferase system to compare the
colonization dynamics of L. plantarum 423 and E. mund-
tii ST4SA in mice. The in vivo BLI system revealed the
precise location of the bacterial strains within the murine
GIT after single or multiple doses. Both strains promin-
ently colonized the cecum and colon. Enterococcus mund-
tii ST4SA persisted in the GIT and faeces of mice
throughout the trial period and also actively colonized the
small intestine. This is the first report of bioluminescence
in vivo imaging of E. mundtii ST4SA in a mouse model.
The bioluminescence system developed here has the po-
tential to allow the study of in vivo colonization dynamics
of other important probiotic LAB species.
Methods
Bacterial strains, plasmid construction and culture
conditions
Escherichia coli MC1061 (Mobitech) was used as a clon-
ing host for construction of pNZ8048-derived biolumines-
cence expression vectors and was cultured aerobically at
37 °C in Luria-Bertani (LB) broth, or brain heart infusion
(BHI) and streaked onto the same media, supplemented
with 1.5% (w/v) agar (all from Biolab Diagnostics, Mid-
rand, South Africa). Lactobacillus plantarum 423 and E.
mundtii ST4SA were grown without shaking at 30 °C in
MRS broth and streaked onto MRS agar (both from
Biolab Diagnostics). Where appropriate, Cm was added at
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10 μg/ml to growth media of E. coli MC1061 and L. plan-
tarum 423 and 5 μg/ml to media of E. mundtii ST4SA.
Lactobacillus plantarum 423 and E. mundtii ST4SA
were labelled by transformation with plasmids encoding
the red-shifted thermostable firefly luciferase gene from P.
pyralis (ffluc) [57]. The bioluminescence expression vec-
tors are based on the pNZ8048 Lc. lactis NICE system
high copy number plasmid (Mobitech, Goettingen,
Germany). The vector contains the cat gene for chloram-
phenicol (Cm) resistance, the nisA gene promoter region
(PnisA), a multiple cloning site (MCS), replication genes
(repC and repA) for replication in LAB/E. coli and the
termination (T) sequence of the Lc. lactis pepN gene [44].
Primers used for PCR amplification are listed in
Additional file 2: Table S1 and were from Inqaba Biotech-
nical Industries (Pretoria, South Africa). DNA restriction
enzymes and PCR polymerase were from New England
Biolabs (NEB, Ipswich, MA, USA). The construction of
pNZPldhFfluc and pNZSTldhFfluc luciferase expression
vectors is shown in Additional file 3: Figure S2. Plasmid
pNZPldhFfluc carried the ffluc gene under control of the
strong constitutive L. plantarum 423 lactate dehydrogen-
ase gene promoter (Pldh). In the pNZSTldhFfluc con-
struct, the ffluc gene was cloned under control of the
strong constitutive E. mundtii ST4SA lactate dehydrogen-
ase gene promoter (STldh). The Pldh and STldh pro-
moters were amplified from L. plantarum 423 and E.
mundtii ST4SA genomic DNA, using primer pairs Pldh1/
Pldh2 and ldhS1/ldhS2, respectively. The ffluc biolumines-
cence gene was amplified from plasmid pMV306G13 +
FflucRT using primers FlucFor and FlucRev. Briefly, the
Pldh (520 bp), STldh (166 bp) and ffluc (1.6 kb) PCR frag-
ments were cloned into pNZ8048 after digestion of Pldh
and STldh with BglII/NcoI, digestion of ffluc with NcoI/
XbaI and digestion of pNZ8048 with BglII/XbaI (resulting
in the removal of the PnisA promoter), yielding plasmids
pNZPldhFfluc and pNZSTldhFfluc, respectively.
The two bioluminescence expression vectors were in-
troduced into L. plantarum 423 and E. mundtii ST4SA
by electro-transformation as described by Van Zyl et al.
[24] and were named L. plantarum 423 Fluc and E.
mundtii ST4SA Fluc. Lactobacillus plantarum 423 and
E. mundtii ST4SA containing the empty pNZ8048
vector were used as controls and were labelled L. plan-
tarum 423 (pNZ8048) and E. mundtii ST4SA
(pNZ8048). Plasmid stability in L. plantarum 423 Fluc
and E. mundtii ST4SA Fluc, and growth comparison
between WT and recombinant strains was tested by
standard methodology as described previously [24].
Correlation between in vitro bioluminescence
measurements and viable cell numbers
Lactobacillus plantarum 423 Fluc and E. mundtii
ST4SA Fluc were grown for 12 h at 30 °C in MRS broth,
supplemented with Cm as mentioned elsewhere. From
these cultures, 1 ml was inoculated into freshly prepared
MRS broth and incubated at 30 °C to an optical density
(OD550nm) of 2.5 (for L. plantarum 423) and 2.3 (for E.
mundtii ST4SA). Viable cell numbers were determined
by plating onto MRS agar containing Cm. The bacterial
suspensions were harvested (3 min at 8000 x g), washed
twice with sterile PBS, resuspended in gavage buffer
(0.2 M NaHCO3 with 1%, w/v, glucose, pH 8.0) and seri-
ally diluted to 1/128 in the same buffer. Two-hundred
microliters of each dilution was added in triplicate to
black 96-well microtitre plates and bioluminescence
measured after the addition of 5 μl of D-Luciferin potas-
sium salt (Anatech Instruments, Bellville, South Africa)
at 470 μM. Bioluminescent readings were recorded using
the IVIS and the photons emitted from regions of inter-
est (ROI) calculated using the Living Image® software,
version 3.0 (Caliper Life Sciences). The ROI of each well
were manually selected. Exposure times ranged from
30 s to 2 min, depending on the intensity of the signal.
Bacterial cell numbers were plotted against biolumines-
cence emitted, recorded as p/s. Non-bioluminescent L.
plantarum 423 (pNZ8048) and E. mundtii ST4SA
(pNZ8048) were used to set the background biolumines-
cence. A modified version of the method by Rhee et al.
[58], was used for the in vitro plasmid stability experiment.
Animals used
Ethical approval for in vivo experiments was granted
by the Ethics Committee of Stellenbosch University
(reference number SU-ACU-2017-0206-454). Eight-
week-old female BALB/c mice were used in all experi-
ments and were obtained from South African Vaccine
Producers (Pty.) Ltd. (Sandringham, Pretoria, South
Africa). Animals were housed in separate cages under
controlled environmental conditions (12 h dark/light
cycles, 20–22 °C). Water and a standard rodent feed
was provided ad libitum and changed daily. Animal
procedures were performed according to the Stellen-
bosch University ethical guidelines.
Preparation of bacterial strains and dosing of mice
Lactobacillus plantarum 423 Fluc and E. mundtii
ST4SA Fluc were grown at 30 °C for 12 h, whereafter
1 ml of each culture was inoculated into freshly prepared
10 ml MRS broth. Lactobacillus plantarum 423 Fluc was
grown to an OD550 of 2.5 and E. mundtii ST4SA Fluc to
an OD550 of 2.3. The cells were harvested (3 min at
8000 x g), washed twice with sterile PBS and resus-
pended in gavage buffer at a final concentration of 4 ×
109 CFU. Mice in each group were then gavaged with
200 μl (4 × 109 CFU) of each strain.
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model
Groups of mice each received a daily dose of 200 μl (4 ×
109 CFU) of live L. plantarum 423 Fluc or E. mundtii
ST4SA Fluc for one (n = 13, per strain) or five (n = 22, per
strain) consecutive days by intragastric gavage. Control
mice (n = 4, per strain) received 200 μl (4 × 109 CFU) of
non-bioluminescent L. plantarum 423 (pNZ8048) or E.
mundtii ST4SA (pNZ8048) in all experiments. Faeces
(100 mg) were collected at different time points and vor-
texed in 1 ml sterile PBS for 5 min, followed by serial dilu-
tion in sterile PBS, and plating onto MRS agar
supplemented with Cm and incubated, as described else-
where. Viable cell numbers were expressed as CFU per
100 mg faeces. Two mice per strain were sacrificed by cer-
vical dislocation at predetermined time points, the intes-
tines surgically removed and immediately separated in a
sterile Petri dish. The lumen of all intestinal sections was
injected with air using a 27-gauge needle and syringe, as
described by Rhee et al. [58], and bioluminescence re-
corded using the IVIS. The complete duodenum, je-
junum, ileum and large intestine (cecum plus colon)
were homogenized, separately, in 3 ml sterile PBS,
serially diluted and plated (in duplicate) onto MRS
agar supplemented with Cm as mentioned elsewhere.
The plates were incubated and cell numbers deter-
mined as described elsewhere.
In vivo bioluminescence measurements
In vivo BLI was recorded using the IVIS, equipped with a
cooled-charged-device camera mounted on a light-tight
specimen chamber (dark box) and a Windows computer
system. Mice were gavaged with 200 μl of a D-Luciferin
potassium salt suspension (30 mg/ml) 30 min before gav-
age with L. plantarum 423 Fluc and E. mundtii ST4SA
Fluc. Mice were anesthetized with 2% (vol/vol) isoflurane
in an oxygen-rich induction chamber before administering
the D-Luciferin and bacteria. Mice were kept subdued
during bioluminescent readings with a mixture of iso-
flurane (1.5%, vol/vol) and oxygen. Mice in ventral
position were imaged for quantification of biolumin-
escent photon emission with exposure times ranging
from 1 to 5 min, depending on the signal intensity.
Pseudo-color images superimposed over grayscale ref-
erence images representing light intensity (red, most
intense and purple being the least intense) were gen-
erated using the Living Image® software program.
ROIs were manually selected and bioluminescence
expressed as photons emitted per second.
Statistical analysis
All data were analysed using GraphPad Prism (version
6.05) and statistical differences between groups were
determined using the Mann-Whitney nonparametric
test. Statistical differences are shown for each data
set. Error was calculated as standard error of mean
(SEM). The number of animals required for each ex-
periment was calculated (power analysis) using the re-
source equation for the sample size.
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Additional file 1: Figure S1. In vitro stability of bioluminescence. (a)
Stability of plasmid pNZPldhFfluc in L. plantarum 423 Fluc and plasmid
pNZSTldhFfluc in E. mundtii ST4SA Fluc after subculturing for 7 days with
replica plating on non-selective (antibiotic-free) and selective (Cm) media.
The percentages of Cm-resistant colonies of three independent cultures
of each respective strain are shown. Bioluminescent colonies of (b) L.
plantarum 423 Fluc and (c) E. mundtii ST4SA Fluc after 7 days of subculture
in antibiotic-free MRS media. (PDF 515 kb)
Additional file 2: Table S1. Primers used in this study. (PDF 497 kb)
Additional file 3: Figure S2. Schematic representing the construction
of the pNZPldhFfluc and pNZSTldhFfluc luciferase expression plasmids.
Relevant features are indicated, including restriction sites and PCR
primers used for cloning; the E. coli/LAB repA and repC replication genes;
the chloramphenicol acetyltransferase (cat) gene conferring resistance to
chloramphenicol; the Pldh promoter from the L. plantarum 423 lactate
dehydrogenase gene and the STldh promoter from the E. mundtii ST4SA
lactate dehydrogenase gene. (PDF 507 kb)
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